HLA
AKAO

Hamilton Lane Advisors’s Achaogen Inc AKAO Stock Holding History

Hamilton Lane Advisors’s Portfolio AKAO Stock Details AKAO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-11,428
Closed -$182K – 68
2017
Q3 		$182K Buy
+11,428
New +$217K 0.13% 47

Other funds holding AKAO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCMI
Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return

Hamilton Lane Advisors's AKAO Position: Q4 2017 in Review

Hamilton Lane Advisors sold out of Achaogen Inc (AKAO) in Q4 2017, closing a stake of 11,428 shares — an estimated $182K sold.

Hamilton Lane Advisors first reported a position in AKAO in Q3 2017 and held it in 1 quarter. The position peaked at $182K in Q3 2017. 103 funds tracked by Wall St. Rank hold AKAO as of Q4 2017.

  • Hamilton Lane Advisors reported no remaining Achaogen Inc position as of Q4 2017 after selling out during the quarter.
  • Hamilton Lane Advisors sold 11,428 Achaogen Inc shares in Q4 2017, an estimated $182K.
  • Hamilton Lane Advisors first reported a position in Achaogen Inc in Q3 2017 and held it in 1 quarter.
  • Hamilton Lane Advisors's Achaogen Inc position peaked at $182K in Q3 2017.
  • 103 funds tracked by Wall St. Rank held Achaogen Inc as of Q4 2017.

Based on Hamilton Lane Advisors's 13F filing for Q4 2017, filed 17 Jan 2018.